BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11339654)

  • 1. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation.
    Rinaldo P; Matern D
    Genet Med; 2000; 2(6):338-44. PubMed ID: 11339654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation.
    Rinaldo P; Studinski AL; Matern D
    Prenat Diagn; 2001 Jan; 21(1):52-4. PubMed ID: 11180241
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatty acid transport and mitochondrial oxidation disorders.
    Rinaldo P
    Semin Liver Dis; 2001 Nov; 21(4):489-500. PubMed ID: 11745037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
    Sim KG; Hammond J; Wilcken B
    Clin Chim Acta; 2002 Sep; 323(1-2):37-58. PubMed ID: 12135806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
    Spiekerkoetter U
    J Inherit Metab Dis; 2010 Oct; 33(5):527-32. PubMed ID: 20449660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.
    Wanders RJ; Ruiter JP; IJLst L; Waterham HR; Houten SM
    J Inherit Metab Dis; 2010 Oct; 33(5):479-94. PubMed ID: 20490924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
    Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
    Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.
    Chalmers RA; Stanley CA; English N; Wigglesworth JS
    J Pediatr; 1997 Aug; 131(2):220-5. PubMed ID: 9290607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.
    Shekhawat PS; Matern D; Strauss AW
    Pediatr Res; 2005 May; 57(5 Pt 2):78R-86R. PubMed ID: 15817498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.
    Lindner M; Hoffmann GF; Matern D
    J Inherit Metab Dis; 2010 Oct; 33(5):521-6. PubMed ID: 20373143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enzymes of mitochondrial fatty acid oxidation.
    Bennett MJ
    Clin Chim Acta; 1994 May; 226(2):211-24. PubMed ID: 7923814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.
    Roe CR
    Semin Neonatol; 2002 Feb; 7(1):37-47. PubMed ID: 12069537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
    Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
    J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders.
    Rinaldo P; Yoon HR; Yu C; Raymond K; Tiozzo C; Giordano G
    Semin Perinatol; 1999 Apr; 23(2):204-10. PubMed ID: 10331471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
    Wanders RJ; Vreken P; den Boer ME; Wijburg FA; van Gennip AH; IJlst L
    J Inherit Metab Dis; 1999 Jun; 22(4):442-87. PubMed ID: 10407780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.
    Waisbren SE; Landau Y; Wilson J; Vockley J
    Dev Disabil Res Rev; 2013; 17(3):260-8. PubMed ID: 23798014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
    Harpey JP; Charpentier C; Paturneau-Jouas M
    Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.